Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.

Forget California and Colorado. Those markets are already well established. If you're looking for where the cannabis industry could find its next meaningful growth opportunities, Virginia and Texas deserve a much closer look. Each state is following a different regulatory path, but both could become important drivers of industry growth over the next few years.

Virginia could become the South's first major adult-use market

Virginia officially approved a regulated retail cannabis market earlier this year. Adult-use sales are scheduled to begin July 1, 2027, with the state ultimately allowing up to 350 retail dispensaries. And that creates a significant opportunity for companies already operating in Virginia's medical market.

Green Thumb Industries (OTC: GTBIF) stands out as a leader here. The company operates one of Virginia's five vertically integrated pharmaceutical processor licenses through its RISE dispensaries. That existing cultivation, processing, and retail infrastructure should give Green Thumb a head start once adult-use sales begin.

It also doesn't hurt that the company is one of the industry's strongest operators. In the second quarter of 2026, Green Thumb generated $306.7 million in revenue, $84.3 million in normalized earnings before interest, taxes, depreciation, and amortization (EBITDA), $29 million in cash flow from operations, and $4.9 million in generally accepted accounting principles (GAAP) net income. The company also ended the quarter with $283.6 million in cash and cash equivalents while continuing to repurchase shares, giving it the financial flexibility to invest in new markets as they open. Unlike many cannabis companies, Green Thumb continues to generate positive operating cash flow, allowing it to fund expansion without relying heavily on new equity financing.

Also consider Verano Holdings (OTC: VRNO), which already operates in Virginia's medical market through a vertically integrated license. This gives it an established cultivation, processing, and retail footprint that could become more valuable when adult-use sales begin.

Virginia is opening the door while Texas is cracking open

Texas remains far from recreational legalization, but there's still opportunity here. The state's Compassionate Use Program has gradually expanded to include more qualifying conditions and additional operators. While patient access does remain limited compared to most medical markets, Texas has a population of more than 32 million people, making even a modest medical market potentially significant over time.

Image source: Getty Images.

Now, late last year, Texas awarded a conditional license to Trulieve Cannabis (NYSE: TRLV), allowing it to establish a presence in the Lone Star State. Green Thumb also secured a conditional dispensing organization license. Those approvals aren't trivial because Texas operates a limited-license system, allowing only a small number of companies to cultivate, process, and dispense medical cannabis. That creates a significant barrier to entry for competitors. If lawmakers continue expanding the state's medical cannabis program, companies that already hold licenses won't have to compete for market access as they'll already be in position to grow alongside the market.

Scale still matters

Legalization headlines often drive cannabis stocks sharply higher, but you should remember that not every company benefits equally. The companies best positioned to capitalize on Virginia and Texas right now already have what newer entrants lack: cultivation facilities, retail operations, regulatory experience, and access to capital.

Green Thumb remains one of the industry's strongest operators because it consistently generates positive cash flow while maintaining a healthy balance sheet. Trulieve, meanwhile, is one of the industry's largest and most consistently profitable operators, giving it the financial resources to expand into new markets as opportunities arise. And Verano has experience building its business around limited-license states, where competition tends to be lower and long-term margins can be stronger.

The truth is, cannabis remains one of the most capital-constrained industries in America. Companies that can fund growth internally have a meaningful advantage over competitors still relying on equity offerings or expensive debt.

To be sure, Virginia and Texas won't transform the industry overnight. Virginia's adult-use market is still nearly a year away, while Texas continues to move at a snail's pace on medical cannabis.

But if you're willing to look beyond just the next quarter, these markets are worth paying attention to. Because the next major cannabis winners may not be determined by federal legalization. They may be determined by which companies already have the infrastructure, licenses, and financial resources in place before these two enormous state markets fully open.

Jeff Siegel has no position in any of the stocks mentioned. The Motley Fool recommends Green Thumb Industries. The Motley Fool has a disclosure policy.